Dr. Eskelund Discusses TP53 Mutated Mantle Cell Lymphoma

Christian Winther Eskelund, MD, Copenhagen University Hospital, Rigshospitalet, discusses TP53-mutated mantle cell lymphoma (MCL).

Christian Winther Eskelund, MD, Copenhagen University Hospital, Rigshospitalet, discusses TP53-mutated mantle cell lymphoma (MCL).

TP53 has been associated with poor outcomes in many different cohorts of MCL, says Eskelund.

Eskelund suggests that TP53 status should be measured upfront in patients who are diagnosed with MCL. As clinical trials become available, treating physicians should highly consider entering their patients onto them.